Rapt Therapeutics Inc (RAPT:NASDAQ)
$57.96 0.03 (0.05%)
Analysed Rapt Therapeutics Inc (RAPT:NASDAQ) News Sources
GSK Expands Pipeline With $950 Million Pulmonary Hypertension Power Play
Benzinga on MSN
GSK to buy 35Pharma for $950 million in CEO Miel's second major deal
Global Banking & Finance Review
GSK to buy Canada's 35Pharma for $950 million
Yahoo Finance UK
Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million
Yahoo Finance
GSK to Buy 35Pharma for $950 Million — Update
Morningstar
Starmer says ‘more to do’ on cost of living despite £117 fall in energy bills from April - as it happened
The Guardian
Hyderabad Biotech Utopia Therapeutics Secures US Patent for Immunotherapy-Based Obesity Vaccine
Medical Dialogues
What is the current price of Rapt Therapeutics Inc (RAPT:NASDAQ)?
The current price of Rapt Therapeutics Inc (RAPT:NASDAQ) is $57.96.
Rapt Therapeutics Inc (RAPT:NASDAQ) absolute price change since previous trading day?
The absolute price change of Rapt Therapeutics Inc (RAPT:NASDAQ) since the previous trading day is $0.03.
Rapt Therapeutics Inc (RAPT:NASDAQ) percentage price change since previous trading day?
The percentage price change of Rapt Therapeutics Inc (RAPT:NASDAQ) since the previous trading day is 0.05%.
What is This Week's average sentiment score for Rapt Therapeutics Inc (RAPT:NASDAQ)?
This Week's average sentiment score for Rapt Therapeutics Inc (RAPT:NASDAQ) is 81 out of 100.
What is This Week's average sentiment for Rapt Therapeutics Inc (RAPT:NASDAQ)?
This Week's sentiment for Rapt Therapeutics Inc (RAPT:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.